Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
about
Diagnostic approach and current treatment options in childhood vasculitisGranulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current KnowledgeGlomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodiesRituximab in diffuse cutaneous systemic sclerosis: should we be using it today?Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Chronic alveolar haemorrhage in a paediatric patient: a diagnostic and treatment challengeANCA-negative Wegener's granulomatosis with multiple lower cranial nerve palsies.Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis.Granulomatosis with polyangiitis in childhood.A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa.Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis.Anti-neutrophil cytoplasmic antibody-negative microscopic polyangiitis: A case report and literature review.Cyclophosphamide in dermatology.Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.Erosive rhinitis resembling granulomatosis with polyangiitis (Wegener's granulomatosis) in an Anatolian shepherd dog.Broadening the translational immunology landscape.Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis.Granulomatosis with Polyangiitis in Children
P2860
Q26765359-652C2D2C-FE1F-4CFA-AE05-2B3ADE1D2F5EQ26765803-303EA907-3A2C-477E-94F3-F5BD5147A08BQ27021715-8C628C74-FF6A-4718-A025-C425B793481CQ27022117-560B03B6-1B5A-4EB8-AAB7-5B633A98027BQ34377832-20E9B792-E702-416A-A78C-9B2139C3BBCAQ35572715-667F7359-0590-463C-BE2B-AD133EC5884BQ37329643-1C9487AE-F2C9-4066-8712-7F75B6B7CF54Q37739043-5F012892-B63F-4B96-88AE-F289E792CEA6Q37979678-6C98D9E0-756D-4241-8E37-DF0137EA49ACQ38030580-B8858C94-CC3F-43FE-9BC8-B55B774B903FQ38100780-83FA687B-5A85-4E81-9F92-0F5DEFDB3499Q38204971-85CF02B7-26FD-4305-B3B0-9EDBD257D5C4Q38334787-7FEEC45D-8ED2-4915-88FA-538A50DD30D1Q38654445-34F370E1-85FA-4A21-966D-83C7DDE7F0DAQ38710150-0C1A4566-AE41-41F4-B7BA-86CD89F84D5DQ40067987-72202AC8-E91F-4077-BA56-0076C0A404B8Q40169677-DB0F8D73-E53B-45D0-8784-AC9E149E0926Q43416268-930E46D1-6DA5-44F2-BAA0-ACE170217EDFQ46723069-1C3D53C6-35DA-4C4A-A1D9-BDEDB41B1D78Q50777385-07E2F926-D412-48A4-951E-349E87BCC78FQ55191066-F266F3EA-3F65-440C-9CA4-49DFEEF587EEQ59160666-2FDBA58E-46F5-487C-954C-B28BFD32C785
P2860
Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@en
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@nl
type
label
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@en
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@nl
prefLabel
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@en
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@nl
P2860
P1476
Cyclophosphamide as induction ...... and microscopic polyangiitis.
@en
P2093
C A Langford
P2860
P356
10.1111/J.1365-2249.2011.04364.X
P478
164 Suppl 1
P577
2011-05-01T00:00:00Z